Members of Samsung’s Strategy and Innovation Center (SSIC) team took the stage last week at San Francisco’s Jazz Center for a trio of announcements. All three releases announced at the “Voice of the Body” event focused on health technology—the company seems determined to beat competitors like Apple to the digital doctor’s office.

Taking things a step further, Samsung also made the case for a common diagnostic platform that could help improve mobile health sensors worldwide. So what’s the prognosis?

Triple Threat

Forbes highlights the SSIC’s three announcements: SAMI, Simband and the Samsung Digital Health Challenge.

A New Vision

SAMI and the Simband jointly form the core of Samsung’s new vision for mobile health sensors—one built on an open platform rather than the more familiar closed-loop used by companies like Apple. As The Telegram recently noted, the establishment of a common system “would be similar to how different computers are built using the same processors and memory chips.” Currently, all Samsung Gear works only with Samsung phones, and in this respect lags behind companies like Sony, whose products work across multiple Android phones.

Samsung’s President and Chief Strategy Officer Young Sohn described his company’s Gear 2 products as second generation, a step up from fitness-tracking apps on smartphones; future generations will focus on detailed vital sign collection and preemptive health warnings. It’s no wonder, then, that Samsung is singing the praises of a common platform for mobile health sensors. Devices have a long way to go before they can move past surface-level statistics, and report more varied, accurate, and intuitive medical data.

Enabling cross-device interoperability and third-party development offers the chance for collaboration and rapid advancement, but makes Samsung a foundational player in the next-gen health market.

Does Samsung have the mobile health prescription, or will users still choose an Apple a day?

Image courtesy of Wikimedia Commons


Tell us your thoughts in the comments:


COMMENTS

No Comments Yet
   

SUBSCRIBE

Login/Register Using:
Close X

Email